2024 ICD-10-CM Diagnosis Code T47.1X1S

Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela

ICD-10-CM Code:
T47.1X1S
ICD-10 Code for:
Poisn by oth antacids and anti-gstrc-sec drugs, acc, sqla
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system
        (T47)

T47.1X1S is a billable diagnosis code used to specify a medical diagnosis of poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

T47.1X1S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like poisoning by other antacids and anti-gastric-secretion drugs accidental (unintentional). According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Accidental aluminum hydroxide overdose
  • Accidental aluminum hydroxide poisoning
  • Accidental carbenoxolone overdose
  • Accidental carbenoxolone poisoning
  • Accidental lansoprazole overdose
  • Accidental lansoprazole poisoning
  • Accidental magnesium trisilicate overdose
  • Accidental magnesium trisilicate poisoning
  • Accidental misoprostol overdose
  • Accidental misoprostol poisoning
  • Accidental omeprazole overdose
  • Accidental omeprazole poisoning
  • Accidental pirenzepine overdose
  • Accidental pirenzepine poisoning
  • Accidental poisoning by anticholinergic
  • Accidental poisoning by anticholinergic
  • Accidental prostaglandin overdose
  • Accidental prostaglandin poisoning
  • Accidental prostaglandin poisoning
  • Accidental sucralfate overdose
  • Accidental sucralfate poisoning
  • Aluminum hydroxide overdose
  • Antacid overdose
  • Anticholinergic drug overdose
  • Anticholinergic drug overdose
  • Carbenoxolone overdose
  • Carbenoxolone poisoning
  • Fetal misoprostol syndrome
  • Lansoprazole overdose
  • Lansoprazole poisoning
  • Magnesium trisilicate overdose
  • Misoprostol overdose
  • Misoprostol poisoning
  • Omeprazole overdose
  • Omeprazole poisoning
  • Pirenzepine overdose
  • Pirenzepine poisoning
  • Poisoning by aluminum hydroxide
  • Poisoning by magnesium trisilicate
  • Prostaglandin overdose
  • Prostaglandin overdose
  • Proton pump inhibitor overdose
  • Proton pump inhibitor poisoning
  • Sucralfate overdose
  • Sucralfate poisoning

Clinical Classification

Clinical Information

  • Burimamide

    an antagonist of histamine that appears to block both h2 and h3 histamine receptors. it has been used in the treatment of ulcers.
  • Carbenoxolone

    an agent derived from licorice root. it is used for the treatment of digestive tract ulcers, especially in the stomach. antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.
  • Enprostil

    a synthetic pge2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. it has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.
  • Metiamide

    a histamine h2 receptor antagonist that is used as an anti-ulcer agent.
  • Misoprostol

    a synthetic analog of natural prostaglandin e1. it produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. it is an effective anti-ulcer agent and also has oxytocic properties.
  • Omeprazole

    a 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of stomach ulcers and zollinger-ellison syndrome. the drug inhibits an h(+)-k(+)-exchanging atpase which is found in gastric parietal cells.
  • Pirenzepine

    an antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. it promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. it also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. it is generally well tolerated by patients.
  • Proglumide

    a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. it is used clinically in the drug therapy of gastrointestinal ulcers.
  • Simethicone

    a poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. it is used as an antiflatulent, surfactant, and ointment base.
  • Sucralfate

    a basic aluminum complex of sulfated sucrose.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Present on Admission (POA)

T47.1X1S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T47.1X1S to ICD-9-CM

  • ICD-9-CM Code: 909.0 - Late eff drug poisoning
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
  • ICD-9-CM Code: E929.2 - Late eff acc poisoning
    Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.

Table of Drugs and Chemicals

The parent code T47.1X1 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Alexitol sodiumT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
AlgeldrateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
AlmagateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
AlmasilateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
AloglutamolT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Antacid NECT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Anti-gastric-secretion drug NECT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
BenexateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
BurimamideT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
CarbenoxoloneT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
CetraxateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Chalk, precipitatedT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Dihydroxyaluminum aminoacetateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Dihydroxyaluminum sodium carbonateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
DimethiconeT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
DimeticoneT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
EnprostilT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
HydrotalciteT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
MagaldrateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Magnesia magmaT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
MethylpolysiloxaneT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
MetiamideT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
Milk of magnesiaT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
MisoprostolT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
OmeprazoleT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
OrnoprostilT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
PepstatinT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
PirenzepineT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
ProglumideT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
RolaidsT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
RosaprostolT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
SimaldrateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
SimethiconeT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
SucralfateT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6
SulglicotideT47.1X1T47.1X2T47.1X3T47.1X4T47.1X5T47.1X6

Patient Education


Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.